Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Tang Kevin bought 167,616 Fulcrum Therapeutics, Inc. shares (Form 4)
Traded Jul 16 to Jul 17, 2026 · Filed Jul 20, 2026
From Jul 16 to Jul 17, 2026, Tang Kevin (10% owner) bought 167,616 Fulcrum Therapeutics, Inc. shares at an average US$3.55 for US$595K, leaving 7,080,945 shares. Filed Jul 20, 2026 (Form 4).
- Bought
- 167,616 shares
- Price
- US$3.55 average (US$3.52 to US$3.56)
- Value
- US$595K
- Holding after
- 7,080,945 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Common Stock | Buy | 116,671 | US$3.56 | 7,030,000 | Indirect |
| Jul 17, 2026 | Common Stock | Buy | 50,945 | US$3.52 | 7,080,945 | Indirect |
Source
Related
- Fulcrum Therapeutics, Inc.
- Tang Kevin
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026